Kiromic BioPharma, Inc.
OTC: KRBP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pietro Bersani CPA,
- Employees
- 44
- Headquarters
- Houston, United States
- IPO year
- 2020
- Market cap
- $214.9K
- Website
- https://www.kiromic.com
Loading KRBP…
Loading profile data…Frequently asked questions about KRBP
What does Kiromic BioPharma, Inc. (KRBP) do?
Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells. Its developmental pipeline...
Where does KRBP trade?
Kiromic BioPharma, Inc. (KRBP) trades on the Other OTC.
What sector is KRBP in?
Kiromic BioPharma, Inc. (KRBP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kiromic BioPharma, Inc.?
Pietro Bersani CPA, is the chief executive officer of Kiromic BioPharma, Inc. (KRBP).
Where is Kiromic BioPharma, Inc. headquartered?
Kiromic BioPharma, Inc. is headquartered in United States.
Does KRBP pay a dividend?
Kiromic BioPharma, Inc. (KRBP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KRBP go public?
Kiromic BioPharma, Inc. (KRBP) completed its initial public offering in 2020.